dc.contributor.author | Kuria, JG | |
dc.contributor.author | Amayo, A. | |
dc.date.accessioned | 2013-10-23T07:13:25Z | |
dc.date.available | 2013-10-23T07:13:25Z | |
dc.date.issued | 2008-09 | |
dc.identifier.citation | East Afr Med J. 2008 Sep;85(9):459-62. | en |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed/19537420 | |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/57839 | |
dc.description.abstract | OBJECTIVE:
To determine prevalence of thyroid antimicrosomal and antithyroglobulin antibodies among patients with primary thyroid disorders.
DESIGN:
Descriptive cross-sectional study.
SETTING:
Kenyatta National Hospital, July 2003 to August 2004.
RESULTS:
Antimicrosomal antibodies (anti-TPOAbs) were detected in 51.4% of all the patients while 36.1% tested positive for the antithyroglobulin antibodies (anti- TgAbs). Among the hyperthyroid patients, anti-TPOAbs and anti-TgAbs were in 50.8% and 33% respectively while 53.3% and 46.7% of the hypothyroid patients tested positive for anti-TPOAbs and anti-TgAbs respectively. Most of the patients who showed positivity for anti-TgAbs (88.5%) also tested positive for anti-TPOAbs.
CONCLUSION:
More than half of the patients with primary thyroid disorders show presence of autoimmune thyroid markers, with anti TPO antibodies being more prevalent. | en |
dc.language.iso | en | en |
dc.publisher | University of Nairobi | en |
dc.title | Prevalence of anti-thyroid antibodies in patients with primary thyroid disorders. | en |
dc.type | Article | en |
local.publisher | school of public health | en |